Calls
1
Shaojing Tong
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Apr 29
$100.10
-
RemeGen had a strong Q1 with 25% revenue growth, maintained gross margins despite price cuts, achieved operational cash flow positive for the first time, and closed a $650 million upfront payment from an out-licensing deal. The company expects strong domestic growth and pipeline delivery over the next 2-3 years, with improving margins and no need for additional financing.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Shaojing Tong has 1 trade ideas tracked on Buzzberg across 1 tickers since April 2026. Most covered: 9995.HK.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
